<DOC>
	<DOC>NCT01847547</DOC>
	<brief_summary>This cohort study plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin and dabigatran) and the occurrence of selected outcomes in patients with non-valvular atrial fibrillation at risk for stroke.</brief_summary>
	<brief_title>Comparative Effectiveness of Oral Anticoagulants</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Inclusion criteria: A recorded diagnosis of atrial fibrillation (AF). Initiation of anticoagulant medication (dabigatran or warfarin). At least 18 years of age on the date of anticoagulant initiation CHA2DS2VAScScore &gt;=1 Exclusion criteria: Patients with missing or ambiguous age or sex information Patients with documented evidence of valvular disease Patients with less than 12 months enrolment in the UnitedHealth Research Database preceding the date of anticoagulant initiation Patients with prior use of any oral anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>